Cidara Therapeutics, Inc.·4

Dec 19, 6:20 PM ET

BURGESS DANIEL D 4

4 · Cidara Therapeutics, Inc. · Filed Dec 19, 2024

Insider Transaction Report

Form 4
Period: 2024-12-17
Transactions
  • Award

    Stock Option (right to buy)

    2024-12-17+20,50020,500 total
    Exercise: $22.81Exp: 2034-12-16Common Stock (20,500 underlying)
Footnotes (1)
  • [F1]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of December 17, 2024.

Documents

1 file
  • 4
    wk-form4_1734650448.xmlPrimary

    FORM 4